CollPlant Biotechnologies Ltd. (ADR)
General ticker "CLGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $15.5M (TTM average)
CollPlant Biotechnologies Ltd. (ADR) does not follow the US Stock Market performance with the rate: -24.2%.
Estimated limits based on current volatility of 5.9%: low 3.36$, high 3.78$
Factors to consider:
- Total employees count: 39 (-31.6%) as of 2025
- Current price 61.9% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [9.08$, 24.50$]
- 2026-12-31 to 2027-12-31 estimated range: [7.79$, 21.06$]
Financial Metrics affecting the CLGN estimates:
- Positive: with PPE of -1.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Positive: Inventory ratio change, % of -26.61 <= -3.92
- Positive: Interest expense per share per price, % of 0.08 <= 0.33
- Positive: -1.23 < Investing cash flow per share per price, % of -0.15
- Positive: 49.86 < Shareholder equity ratio, % of 56.38 <= 58.56
Short-term CLGN quotes
Long-term CLGN plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $0.52MM | $2.37MM |
| Operating Expenses | $17.77MM | $13.85MM |
| Operating Income | $-17.25MM | $-11.48MM |
| Non-Operating Income | $0.64MM | $-0.01MM |
| Interest Expense | $0.02MM | $0.01MM |
| R&D Expense | $10.52MM | $8.19MM |
| Income(Loss) | $-16.61MM | $-11.49MM |
| Net Income(Loss)* | $-16.61MM | $-11.49MM |
| Stockholders Equity | $13.46MM | $6.08MM |
| Inventory | $0.44MM | $0.57MM |
| Assets | $18.71MM | $10.79MM |
| Operating Cash Flow | $-14.09MM | $-9.42MM |
| Capital expenditure | $0.48MM | $0.03MM |
| Investing Cash Flow | $-0.54MM | $-0.03MM |
| Financing Cash Flow | $0.01MM | $3.10MM |
| Earnings Per Share** | $-14.50 | $-9.41 |
| Ordinary share to ADR | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.